Key result
Elimination of multiple N-glycosylation sites resulted in intracellular accumulation of desmocollin-2 within the Golgi apparatus, whereas elimination of O-mannosylation sites or disulfide bridges had no obvious effect on trafficking.
Why the study?
The functional relevance of post-translational modifications in the extracellular domain of desmocollin-2 for protein trafficking to the plasma membrane was unknown.
Multiple N-glycosylation sites are required for the efficient intracellular transport of desmocollin-2 to the plasma membrane, providing insight into the basic biology of desmosomal proteins involved in arrhythmogenic cardiomyopathy.
Should not yet change arrhythmogenic cardiomyopathy management; leaves open whether N-glycosylation defects drive desmosomal dysfunction in patients.
Desmocollin-2 (DSC2) is a desmosomal protein of the cadherin family. Desmosomes are multiprotein complexes, which are involved in cell adhesion of cardiomyocytes and of keratinocytes. The molecular structure of the complete extracellular domain (ECD) of DSC2 was recently described, revealing three disulfide bridges, four N-glycosylation sites, and four O-mannosylation sites. However, the functional relevance of these post-translational modifications for the protein trafficking of DSC2 to the plasma membrane is still unknown. Here, we generated a set of DSC2 mutants, in which we systematically exchanged all N-glycosylation sites, O-mannosylation sites, and disulfide bridges within the ECD and investigated the resulting subcellular localization by confocal laser scanning microscopy. Of note, all single and double N-glycosylation- deficient mutants were efficiently incorporated into the plasma membrane, indicating that the absence of these glycosylation sites has a minor effect on the protein trafficking of DSC2. However, the exchange of multiple N-glycosylation sites resulted in intracellular accumulation. Colocalization analysis using cell compartment trackers revealed that N-glycosylation- deficient DSC2 mutants were retained within the Golgi apparatus. In contrast, elimination of the four O-mannosylation sites or the disulfide bridges in the ECD has no obvious effect on the intracellular protein processing of DSC2. These experiments underscore the importance of N-glycosylation at multiple sites of DSC2 for efficient intracellular transport to the plasma membrane.
No takes yet. Share an insight, caveat, or question.
Brodehl et al. (2019) studied Arrhythmogenic (right ventricular) cardiomyopathy (context). Site-directed mutagenesis of DSC2 (N-glycosylation, O-mannosylation, and disulfide bridge sites) vs. Wild-type DSC2 was evaluated on Subcellular localization of DSC2 (plasma membrane vs intracellular accumulation). Elimination of multiple N-glycosylation sites resulted in intracellular accumulation of desmocollin-2 within the Golgi apparatus, whereas elimination of O-mannosylation sites or disulfide bridges had no obvious effect on trafficking.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: